Efficacy and safety of peg-IFN+RBV combined therapy in failure of direct antiviral agents therapy for chronic hepatitis C and liver cirrhosis C
Not Applicable
- Conditions
- Chronic hepatitis and compensated liver cirrhosis, type C
- Registration Number
- JPRN-UMIN000017988
- Lead Sponsor
- Faculty of Medicine, Kyushu University Dept. of Medicine and Biosyste
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Not provided
Exclusion Criteria
un-tolerable for combined therapy de compensated liver cirrhosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sustained virological response
- Secondary Outcome Measures
Name Time Method